Apexigen, Inc.
APGN · NASDAQ
12/31/2022 | 12/31/2021 | 12/31/2020 | |
|---|---|---|---|
| Revenue | $0 | $0 | $0 |
| % Growth | – | – | – |
| Cost of Goods Sold | $0 | $0 | $0 |
| Gross Profit | $0 | $0 | $0 |
| % Margin | – | – | – |
| R&D Expenses | $23,035 | $21,664 | $18,770 |
| G&A Expenses | $9,651 | $7,293 | $5,774 |
| SG&A Expenses | $9,651 | $7,293 | $5,774 |
| Sales & Mktg Exp. | $0 | $0 | $0 |
| Other Operating Expenses | $0 | $0 | $0 |
| Operating Expenses | $32,686 | $28,957 | $24,544 |
| Operating Income | -$32,686 | -$28,957 | -$24,544 |
| % Margin | – | – | – |
| Other Income/Exp. Net | $617 | $41 | $421 |
| Pre-Tax Income | -$32,069 | -$28,916 | -$24,123 |
| Tax Expense | -$617 | -$41 | -$421 |
| Net Income | -$31,452 | -$28,875 | -$23,702 |
| % Margin | – | – | – |
| EPS | -1.59 | -0.93 | -0.76 |
| % Growth | -71% | -22.4% | – |
| EPS Diluted | -1.59 | -0.93 | -0.76 |
| Weighted Avg Shares Out | 19,787 | 31,071 | 31,071 |
| Weighted Avg Shares Out Dil | 19,787 | 31,071 | 31,071 |
| Supplemental Information | – | – | – |
| Interest Income | $0 | $41 | $421 |
| Interest Expense | -$617 | $0 | $0 |
| Depreciation & Amortization | $110 | $105 | $127 |
| EBITDA | -$32,576 | -$28,852 | -$24,417 |
| % Margin | – | – | – |